Joshua Silverman insider trades
Open-market stock purchases and sales by Joshua Silverman, Executive Chairman at Q/C Technologies, Inc, from SEC Form 4 filings since Jun 17, 2016.
Track record: 50% of 6 scored buys are up 5% or more since purchase, averaging +11%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | QCLS Q/C Technologies, Inc | Bought (not open market) | — |
| Sep 30, 2026 | FABC Fabric.AI, Inc | Sold (not open market) | $102K |
| Jul 10, 2026 | QCLS Q/C Technologies, Inc | Bought (not open market) | — |
| Jun 30, 2026 | FABC Fabric.AI, Inc | Sold (not open market) | $165K |
| Jun 18, 2026 | FABC Fabric.AI, Inc | Bought (not open market) | — |
| Jun 18, 2026 | FABC Fabric.AI, Inc | Sold (not open market) | $166K |
| Jun 5, 2026 | PTPI Petros Pharmaceuticals, Inc | Bought (not open market) | — |
| May 18, 2026 | TAOX TAO Synergies Inc | Bought (not open market) | — |
| Apr 13, 2026 | QCLS Q/C Technologies, Inc | Bought (not open market) | — |
| Apr 13, 2026 | QCLS Q/C Technologies, Inc | Bought (not open market) | — |
| Apr 13, 2026 | QCLS Q/C Technologies, Inc | Bought (not open market) | — |
| Apr 13, 2026 | QCLS Q/C Technologies, Inc | Bought (not open market) | — |
| Jan 7, 2026 | PMCB PharmaCyte Biotech, Inc | Bought | $33.3K |
| Jan 6, 2026 | PMCB PharmaCyte Biotech, Inc | Bought | $23.7K |
| Jan 5, 2026 | PMCB PharmaCyte Biotech, Inc | Bought | $23.5K |
| Jan 2, 2026 | PTPI Petros Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 12, 2025 | PMCB PharmaCyte Biotech, Inc | Bought (not open market) | — |
| Dec 12, 2025 | PMCB PharmaCyte Biotech, Inc | Sold (not open market) | $264K |
| Nov 14, 2025 | QCLS Q/C Technologies, Inc | Bought (not open market) | — |
| Oct 31, 2025 | SBLX StableX Technologies, Inc | Bought (not open market) | — |
Companies traded
- QCLS Q/C Technologies, Inc: other filings, last Oct 1, 2026
- FABC Fabric.AI, Inc: other filings, last Sep 30, 2026
- PTPI Petros Pharmaceuticals, Inc: other filings, last Jun 5, 2026
- TAOX TAO Synergies Inc: other filings, last May 18, 2026
- PMCB PharmaCyte Biotech, Inc: 3 buys, last Jan 7, 2026
- SBLX StableX Technologies, Inc: other filings, last Oct 31, 2025
- FEMY Femasys Inc: other filings, last Jun 25, 2025
- AYRO AYRO, Inc: 6 sales, last Dec 2, 2024
- SNPX Synaptogenix, Inc: 1 buy, 1 sale, last Apr 8, 2024
- MYMD MyMD Pharmaceuticals, Inc: 3 buys, last Jun 7, 2023
- NTRP Neurotrope, Inc: 2 buys, last Dec 1, 2020
- AKER Akers Biosciences, Inc: other filings, last Sep 11, 2020